Author

Daniel Doherty

Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain;ORCID 0000-0001-8522-7658Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Daniel Doherty4 papers · University of Washington

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1 Assay:structural biology· 1

Frequent Co-Authors

Adrià Nicolàs-AragóiD· 1 shared Ekaitz Errasti-MurugarreniD· 1 shared Els PardoniD· 1 shared Jan SteyaertiD· 1 shared Joana FortiD· 1 shared Manuel PalacíniD· 1 shared Paola Chiara BartoccioniiD· 1 shared Patricia Gómez-GejoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adrià Nicolàs-AragóORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivPreprintNov 13, 2026

Experimental and computational mapping reveals preferential nanobody targeting of the intracellular cavity of the amino acid transporter BasC

Adrià Nicolàs-Aragó, Daniel Doherty, Patricia Gómez-Gejo…·Joana Fort

The paper characterizes 29 nanobodies targeting BasC using biochemical assays, structural data, and AlphaFold3, revealing a bias toward intracellular binding and validating epitope clusters.

DOI 10.64898/2026.11.11.765408

bacteria (other)structural biology

𝕏 PostBluesky